Sutro Biopharma Reports First Quarter 2019 Financial Results and Recent Business Highlights and Developments

Wednesday, May 15, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

STRO-001 Ongoing Phase 1 Trial in Myeloma and Lymphoma with Initial Safety Data to be presented at the European Hematology Association ("EHA") Congress, June 15, 2019

 (1)

The condensed balance sheet as of March 31, 2019 was derived from the unaudited financial

statements included in the Company's Quarterly Report on Form 10-Q for the quarter ended

March 31, 2019, filed with the Securities and Exchange Commission on May 15, 2019.

(2)

The condensed balance sheet as of December 31, 2018 was derived from the audited financial

statements included in the Company's Annual Report on Form 10-K for the year ended December

31, 2018, filed with the Securities and Exchange Commission on March 29, 2019.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store